Can MedIntuit support the entire scientific advisory board or only specific components?

Both. MedIntuit can support the full scientific lifecycle of a scientific advisory board or provide targeted support for specific needs such as KOL strategy, agenda development, scientific content, facilitation, or post-meeting insight synthesis.

Can you help identify and map the right experts for an advisory board?

Yes. We can support KOL mapping, advisor profiling, and development of selection criteria based on therapeutic area, scientific expertise, practice setting, stakeholder perspective, geography, and other relevant factors. Final selection and engagement of advisors remains with the client.

What is the difference between a medical advisory board and a broader expert meeting?

A medical advisory board is typically structured around defined scientific or Medical Affairs questions and is designed to generate external expert perspectives that can inform strategy, evidence planning, stakeholder engagement, or other Medical Affairs priorities. MedIntuit helps ensure the meeting objectives, participants, discussion flow, and outputs are aligned with those goals.

Can MedIntuit facilitate a KOL advisory board?

Yes. MedIntuit can provide scientific facilitation or moderation for a KOL advisory board, including virtual and in-person formats. Facilitation is designed to support balanced discussion, explore differing expert perspectives, and keep the conversation aligned with the board's scientific objectives.

Can you support a pharmaceutical advisory board before launch?

Yes. A pharmaceutical advisory board can help Medical Affairs teams better understand the treatment landscape, unmet needs, evidence gaps, stakeholder perspectives, and scientific communication needs ahead of launch or another key milestone.

What happens after the advisory board meeting?

Post-meeting support can include synthesis of key themes, areas of consensus and disagreement, unmet needs, evidence gaps, unanswered questions, and potential implications for Medical Affairs. We can also help translate those insights into prioritized next steps.

Do you handle advisory board logistics, contracts, or honoraria?

MedIntuit's core role is scientific and Medical Affairs support. The specific engagement can be coordinated with the client's internal teams or external meeting partners responsible for contracting, honoraria, travel, venue logistics, and other operational requirements.

Can this support an ongoing pharma advisory board program rather than a single meeting?

Yes. MedIntuit can support an individual pharma advisory board or a broader series of expert engagements, helping maintain continuity in scientific objectives, advisor strategy, discussion themes, insight capture, and follow-through over time.

Advisory boards can generate some of the most valuable external scientific insights available to a Medical Affairs team, but only when the right experts are in the room, the right questions are being asked, and the discussion is structured to produce meaningful insight.

MedIntuit supports pharma and biotech companies across the scientific lifecycle of a scientific advisory board or medical advisory board, from defining objectives and identifying the right advisor profiles through agenda development, scientific content, facilitation, insight capture, and post-meeting synthesis.

Whether the goal is to explore an evolving treatment landscape, understand unmet needs, pressure-test a scientific strategy, prepare for a launch, or gather expert perspectives around a specific clinical question, we help ensure the pharma advisory board is designed around the decisions your Medical Affairs team actually needs to make.

Advisory Board Scientific Support

Pharmaceutical advisory board meeting where experts discuss clinical questions with a Medical Affairs team

What This Service Includes

Advisory Board Strategy and Objective Setting

We work with your team to define the scientific and strategic questions the scientific advisory board needs to address, ensuring the meeting is built around clear objectives rather than a broad discussion without a defined outcome.

Advisor Identification, KOL Mapping, and Selection strategy

We help define the expertise, experience, geographic representation, practice setting, and stakeholder perspectives needed for the discussion. Support may include KOL mapping, advisor profiling, and development of selection criteria, with final advisor selection remaining with the client.

Agenda and Discussion Guide Development

We translate advisory board objectives into a structured agenda and focused discussion guide designed to encourage meaningful scientific exchange while keeping the conversation aligned with the questions your team needs answered.

Scientific Content Development and Review

We support the development or refinement of scientific background materials, pre-reads, presentations, discussion prompts, evidence summaries, and other materials needed to prepare advisors and facilitate an informed discussion.

Insight Capture and Synthesis

We organize advisory board feedback into clear scientific themes, areas of agreement and divergence, unanswered questions, evidence gaps, and potential implications for Medical Affairs

Who this is for

Pre-launch and commercial-stage pharma or biotech companies seeking external scientific perspectives around a product, pipeline, or treatment landscape
Medical Affairs teams planning a scientific advisory board or medical advisory board that need additional strategy, content, facilitation, or insight support
Emerging companies conducting their first pharmaceutical advisory board and looking for an experienced Medical Affairs partner to help establish the approach
Teams entering a new therapeutic area or indication that need structured input from external experts
Medical Affairs leaders seeking deeper, more actionable insights from an existing advisory board program
Organizations planning a KOL advisory board around a launch, evidence gap, treatment landscape, or other defined scientific question

Potential Deliverables

Depending on the engagement, support may include:

Advisory board strategy and objectives
Advisor profile and selection criteria
KOL mapping and expert landscape assessment
Advisory board agenda
Discussion guide and moderator questions
Scientific background materials
Pre-read or evidence summary
Presentation development or scientific review
Facilitator or moderator guide
Live scientific facilitation
Structured insight-capture framework
Post-meeting insight report
Key themes and areas of consensus or divergence
Evidence-gap and unmet-need summary
Medical Affairs implications and recommended next steps
Pharmaceutical advisory board planning and scientific support

Meeting Facilitation and Scientific moderation

MedIntuit can provide experienced scientific facilitation for virtual or in-person advisory boards, including a KOL advisory board or other expert scientific forum, helping guide discussion, explore differing perspectives, probe important themes, and ensure all participants have an opportunity to contribute.

Post-Advisory Board recommendations

We help translate the discussion into actionable next steps, including questions for further investigation, stakeholder engagement priorities, evidence-generation considerations, scientific communication needs, or other Medical Affairs activities.

How it works

STEP 01

Define the Objectives:

We work with your team to identify the scientific questions, business context, desired expert perspectives, and decisions the advisory board is intended to inform..

STEP 02

Design the Advisory Board:

We develop the advisor framework, KOL mapping approach, agenda, discussion flow, scientific materials, facilitation strategy, and insight-capture plan around those objectives..

STEP 03

Facilitate and Capture:

When included in scope, MedIntuit facilitates the pharma advisory board meeting and supports structured capture of scientific perspectives, questions, and emerging themes.

STEP 04

Synthesize and Translate:

We organize the discussion into clear insights and help identify the implications, follow-up questions, and Medical Affairs actions that should come next.

Frequently Asked Questions

Both. MedIntuit can support the full scientific lifecycle of a scientific advisory board or provide targeted support for specific needs such as KOL strategy, agenda development, scientific content, facilitation, or post-meeting insight synthesis.
Yes. We can support KOL mapping, advisor profiling, and development of selection criteria based on therapeutic area, scientific expertise, practice setting, stakeholder perspective, geography, and other relevant factors. Final selection and engagement of advisors remains with the client.
A medical advisory board is typically structured around defined scientific or Medical Affairs questions and is designed to generate external expert perspectives that can inform strategy, evidence planning, stakeholder engagement, or other Medical Affairs priorities. MedIntuit helps ensure the meeting objectives, participants, discussion flow, and outputs are aligned with those goals.
Yes. MedIntuit can provide scientific facilitation or moderation for a KOL advisory board, including virtual and in-person formats. Facilitation is designed to support balanced discussion, explore differing expert perspectives, and keep the conversation aligned with the board's scientific objectives.
Yes. A pharmaceutical advisory board can help Medical Affairs teams better understand the treatment landscape, unmet needs, evidence gaps, stakeholder perspectives, and scientific communication needs ahead of launch or another key milestone.
Post-meeting support can include synthesis of key themes, areas of consensus and disagreement, unmet needs, evidence gaps, unanswered questions, and potential implications for Medical Affairs. We can also help translate those insights into prioritized next steps.
MedIntuit's core role is scientific and Medical Affairs support. The specific engagement can be coordinated with the client's internal teams or external meeting partners responsible for contracting, honoraria, travel, venue logistics, and other operational requirements.
Yes. MedIntuit can support an individual pharma advisory board or a broader series of expert engagements, helping maintain continuity in scientific objectives, advisor strategy, discussion themes, insight capture, and follow-through over time.

Planning an upcoming advisory board?

Contact MedIntuit Consulting to build a scientifically rigorous engagement that brings the right experts, questions, and insights together around your Medical Affairs priorities.